Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 193

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 193
---
 all of the assets of Aadi under the DGCL is highly fact-specific, and because Aadi’s board of directors considered the action
appropriate and strongly desire the input of Aadi stockholders, given the financial significance of the FYARRO Business.

The transaction is expected to
close in the first half of 2025, subject to Aadi stockholder approval and certain closing conditions. Upon the closing of this transaction, Kaken will also acquire the rights to the Aadi name and trademark.

Aadi’s board of directors has determined that the Divestiture is advisable and in the best interests of Aadi, and has approved the Divestiture Agreement
and the Divestiture. A copy of the Divestiture Agreement is attached as Annex A to this proxy statement and incorporated herein by reference. Aadi stockholders are urged to carefully read the Divestiture Agreement in its entirety.

Consequences if the Divestiture Proposal is Not Approved

If the Aadi stockholders do not approve the Divestiture Proposal, the Divestiture will not be completed. If the Divestiture is not completed, the Divestiture
Agreement provides that, upon termination of the Divestiture Agreement under certain circumstances, Aadi may be required to pay to Kaken a termination fee of $3.5 million.

Required Vote

The approval of the Divestiture Proposal
requires the affirmative vote in person or by proxy of a majority of the outstanding shares of our common stock entitled to vote at the Special Meeting. Aadi stockholders may vote “FOR,” “AGAINST” or “ABSTAIN.” Failures
to vote, abstentions and broker non-votes, if any, will all be counted in the same manner as votes “AGAINST” the Divestiture Proposal.

THE AADI BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” APPROVAL OF THE DIVESTITURE PROPOSAL

- 131 -

PROPOSAL NO. 2:

APPROVAL OF THE PIPE FINANCING PROPOSAL

THE AADI BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT AADI STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE PIPE FINANCING.

Overview

At the Meeting, Aadi stockholders will be asked
to approve, in accordance with applicable rules of the Nasdaq Stock Market, the issuance of shares of Aadi’s common stock in the PIPE Financing. The net proceeds from the PIPE Financing are expected to be used